William B. O'Connor
2014
In 2014, William B. O'Connor earned a total compensation of $1.2M as Chief Financial Officer at Medicines, a 8% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $183,094 |
---|---|
Option Awards | $318,871 |
Salary | $393,750 |
Stock Awards | $320,897 |
Other | $3,214 |
Total | $1,219,826 |
O'Connor received $393.8K in salary, accounting for 32% of the total pay in 2014.
O'Connor also received $183.1K in non-equity incentive plan, $318.9K in option awards, $320.9K in stock awards and $3.2K in other compensation.
Rankings
In 2014, William B. O'Connor's compensation ranked 6,695th out of 13,032 executives tracked by ExecPay. In other words, O'Connor earned more than 48.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,695 out of 13,032 | 49th |
Division Manufacturing | 2,455 out of 4,966 | 51st |
Major group Chemicals And Allied Products | 827 out of 1,686 | 51st |
Industry group Drugs | 650 out of 1,365 | 52nd |
Industry Pharmaceutical Preparations | 495 out of 1,043 | 53rd |
Source: SEC filing on April 26, 2017.
O'Connor's colleagues
We found four more compensation records of executives who worked with William B. O'Connor at Medicines in 2014.